Literature DB >> 16502763

Antidiabetic medications in overdose: a comparison of the inquiries made to a regional poisons unit regarding original sulfonylureas, biguanides and insulin.

M A von Mach1, M Gauer, S Meyer, B Omogbehin, H Schinzel, P H Kann, L S Weilemann.   

Abstract

OBJECTIVE: The drugs most commonly used to treat diabetes mellitus are sulfonylureas, biguanides and insulin. The most serious effects seen in overdose with these agents are hypoglycemia or lactic acidosis which may be fatal or cause cerebral defects. The present investigation analyzes inquiries made to a regional poisons unit involving overdoses with sulfonylureas, biguanides and insulin. PATIENTS AND METHODS: A total of 218,070 made inquiries between 1995 and 2004 were evaluated. The inquiries were received by telephone and a standardized questionnaire was sent subsequently to the physicians calling for follow-up information. The cases were analyzed with regard to gender, age, etiology, symptoms and clinical outcome.
RESULTS: 263 inquiries concerning sulfonylureas (48.3% female, 49.4% male, 2.3% sex unknown, average age 39.1 +/- 26.8 years), 172 concerning biguanides (60.5% female, 37.2% male, 2.3% sex unknown, average age 41.5 +/- 24.1 years), and 191 concerning insulin (53.9% female, 41.9% male, 4.2% sex unknown, average age 44.6 +/- 16.7) were made. In cases involving sulfonylureas, the etiology was deliberate self-poisoning in 62.7% and accidental in 31.9% (biguanides 60.5% and 29.1%, insulin 85.3% and 9.4%). Using the Poisoning Severity Score, no symptoms were observed in 41.4% of the patients with sulfonylurea overdose (biguanides 40.1%, insulin 22.5%), minor symptoms in 37.6% (biguanides 32.6%, insulin 33.5%), major symptoms in 14.4% (biguanides 13.4%, insulin 26.2%) and serious symptoms in 4.6% (biguanides 12.2%, insulin 14.7%). Returned questionnaires reporting clinical outcomes showed that a full recovery occurred in most patients (sulfonylureas 97.4%, biguanides 93.0%, insulin 94.4%), cerebral defects persisted in 1.8% of the cases involving sulfonylureas (biguanides 1.5%, insulin 2.4%), and that 0.9% of the patients with sulfonylurea overdose died (biguanides 6.1%, insulin 3.6%).
CONCLUSIONS: Sulfonylureas were the most frequently observed medication in cases of overdose with antidiabetic agents. Insulin overdose caused the highest number of major and serious symptoms. Overdose with biguanides led to the most deaths.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16502763     DOI: 10.5414/cpp44051

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther        ISSN: 0946-1965            Impact factor:   1.366


  8 in total

Review 1.  How do kinases contribute to tonicity-dependent regulation of the transcription factor NFAT5?

Authors:  Xiaoming Zhou
Journal:  World J Nephrol       Date:  2016-01-06

2.  Insulin overdose among patients with diabetes: a readily available means of suicide.

Authors:  Kristin S Russell; Jonathan R Stevens; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

Review 3.  [Mental disorders and diabetes mellitus].

Authors:  Heidemarie Abrahamian; Alexandra Kautzky-Willer; Angelika Rießland-Seifert; Peter Fasching; Christoph Ebenbichler; Peter Hofmann; Hermann Toplak
Journal:  Wien Klin Wochenschr       Date:  2016-04       Impact factor: 1.704

4.  [Mental disorders and diabetes mellitus].

Authors:  Heidemarie Abrahamian; Alexandra Kautzky-Willer; Angelika Rießland-Seifert; Peter Fasching; Christoph Ebenbichler; Peter Hofmann; Hermann Toplak
Journal:  Wien Klin Wochenschr       Date:  2012-12       Impact factor: 1.704

Review 5.  Should We Be Using the Poisoning Severity Score?

Authors:  Evan S Schwarz; Kathryn T Kopec; Timothy J Wiegand; Paul M Wax; Jeffrey Brent
Journal:  J Med Toxicol       Date:  2017-03-10

6.  Secular Trends in the Clinical Characteristics of Type 2 Diabetic Patients With Severe Hypoglycemia Between 2008 and 2013.

Authors:  Hiroyuki Ito; Emiko Tsugami; Shigenori Ando; Ayano Imai; Suzuko Matsumoto; Takashi Omoto; Masahiro Shinozaki; Shinya Nishio; Mariko Abe; Shinichi Antoku; Mizuo Mifune; Michiko Togane
Journal:  J Clin Med Res       Date:  2016-08-30

7.  Intentional overdose with insulin: prognostic factors and toxicokinetic/toxicodynamic profiles.

Authors:  Bruno Mégarbane; Nicolas Deye; Vanessa Bloch; Romain Sonneville; Corinne Collet; Jean-Marie Launay; Frédéric J Baud
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

Review 8.  The Other Face of Insulin-Overdose and Its Effects.

Authors:  Szymon Rzepczyk; Klaudia Dolińska-Kaczmarek; Aleksandra Uruska; Czesław Żaba
Journal:  Toxics       Date:  2022-03-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.